» Articles » PMID: 12048191

Nongenomic Testosterone Calcium Signaling. Genotropic Actions in Androgen Receptor-free Macrophages

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Jun 6
PMID 12048191
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Steroid hormones exert genotropic actions through members of the nuclear receptor family. Here, we have demonstrated genotropic actions of testosterone that are independent of intracellular androgen receptors (iAR). Through plasma membrane androgen receptors (mAR), testosterone induces a rapid rise in the intracellular free Ca(2+) concentration of iAR-free murine RAW 264.7 macrophages. This nongenomic testosterone signaling, which is independent of both iAR and estrogen receptors, does not in itself activate either the mitogen-activated protein kinase (MAPK) families ERK1/2, p38, and JNK/SAPK, the stably and transiently transfected c-fos promoter, or NO production. In the context of lipopolysaccharide (LPS) signaling, however, testosterone attenuates LPS activation of the c-fos promoter and NO production, which is abolished by the intracellular Ca(2+) chelator BAPTA. Testosterone also attenuates the LPS activation of p38 but not that of ERK1/2 and JNK/SAPK, and this attenuation is abrogated by BAPTA. Moreover, the p38 inhibitor, SB 203580, largely reduces LPS activation of the c-fos promoter and NO production, and the remaining levels are no longer regulated by testosterone. This study is the first to provide information on genotropic actions of mAR-mediated nongenomic testosterone Ca(2+) signaling by cross-talk with the LPS signaling pathway through p38 MAPK with impact on cell function.

Citing Articles

Testosterone acts through the membrane protein GPRC6A to cause cardiac edema in zebrafish embryos.

Zadmajid V, Shahriar S, Gorelick D Development. 2024; 151(23).

PMID: 39479956 PMC: 11634029. DOI: 10.1242/dev.204390.


Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs.

Yanes Cardozo L, Romero D FASEB J. 2021; 35(11):e21945.

PMID: 34606638 PMC: 10146586. DOI: 10.1096/fj.202002526RR.


Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL.

Lee G, Kim J, Kwon S, Stein M, Hong J, Nagaya N Endocrinology. 2019; 160(9):2049-2060.

PMID: 31184711 PMC: 6691685. DOI: 10.1210/en.2019-00367.


Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.

Yao P, Zhuo S, Mei H, Chen X, Li N, Zhu T CNS Neurosci Ther. 2017; 23(11):855-865.

PMID: 28941188 PMC: 6492702. DOI: 10.1111/cns.12757.


Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation.

Liao R, Ma S, Miao L, Li R, Yin Y, Raj G Transl Androl Urol. 2016; 2(3):187-96.

PMID: 26816736 PMC: 4708176. DOI: 10.3978/j.issn.2223-4683.2013.09.07.